A carregar...
Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer
Immune checkpoint inhibitors (ICI) have been validated as an effective new treatment strategy in several tumoral types including lung cancer. This remarkable shift in the therapeutic paradigm is in large part due to the duration of responses and long-term survival seen with ICI. However, despite thi...
Na minha lista:
| Publicado no: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8264336/ https://ncbi.nlm.nih.gov/pubmed/34295689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-839 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|